Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin.
about
Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation.Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicinEstablishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin.Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells.Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposureSynthesis and biological evaluation of new geiparvarin derivatives.Mycobacterium avium-intracellulare contamination of mammalian cell cultures.Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.Synergism between gamma interferon and doxorubicin in a human MDR colon adenocarcinoma cell line.Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cells.Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts.Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline.Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas.Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.P-glycoprotein expression in de novo acute myeloid leukemia.Anticancer activity of a cis-dichloridoplatinum(ii) complex of a chelating nitrogen mustard: insight into unusual guanine binding mode and low deactivation by glutathione.Reversal of multidrug resistance by new dihydropyridines with low calcium antagonist activity.A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes.Oxidative degradation of polyamines by serum supplement causes cytotoxicity on cultured cells.Killing of Tumor Cells with Pleiotropic Drug Resistance by OK432-Activated Effector Cells
P2860
Q35977919-E8B079F5-C4CB-4377-AE58-68BB10BDC5D3Q35993083-0E8D19F6-3BC7-479D-9375-E06E7F1861A6Q36080587-0BDC550B-FF03-4484-92D2-6C3F97F64BBAQ36135764-C12836D2-1DBA-47C5-9CDD-A6B693401558Q36284267-EC0EBAB5-53AD-4DDB-A49F-DA871316417AQ36422357-3922518A-05EE-4951-93E9-E9B9EDB5DD37Q38801730-01F705D1-4A92-400B-91FE-884489879F33Q39709029-2A305EC9-7824-4EC7-B871-4F2368343D97Q39711105-2721F23E-F259-4529-81E2-CB2DCA48F8C5Q39868045-664A142A-598D-464B-95B7-B37BE3E8EEE3Q39929352-BDAF5DD8-4792-4B81-AF32-E78B2FCDD972Q39998933-0CCFC261-8DDB-4300-AE33-15F5ED863B5AQ41282935-DC1FFEC3-47CF-41E9-981B-A1910CA500E9Q41439278-652E6F64-7582-4C54-9602-1B9D1C297B4FQ41520151-FF25B4B4-1EB5-4EF6-84D9-F6FE5B118C06Q41764813-37344503-F750-48A8-AA61-979677CCFA11Q42520007-7AAA4F7C-B03E-405C-A19A-486596BEE063Q48117054-33B8FBA0-86CA-45E1-A0BE-8717905E21F4Q48684788-B3BB8CFF-49A7-4FFA-8B86-CD3C9129DF5EQ49236261-8A59F92B-F068-4E25-8705-9E288B4992E8Q50918570-889F94D3-DE3A-44C6-BB1A-D43202A9E58FQ52887316-BCA12BBD-55E4-498D-9DFC-D8EA4CA38DF5Q54220488-41C2866B-790F-40D7-B10E-0E5D927DF353Q54249265-69F100ED-D299-45A5-8711-EAEBEB45E383Q54403248-A9F72923-0BD7-4D0A-BA6C-C4AE1598368BQ55713100-B43E34B4-1B24-462B-9ED1-CC7A574148C3Q56943722-A31B29FF-2A3E-4CDB-AD8D-8655E184AEF7
P2860
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Isolation and characterization ...... line resistant to doxorubicin.
@en
type
label
Isolation and characterization ...... line resistant to doxorubicin.
@en
prefLabel
Isolation and characterization ...... line resistant to doxorubicin.
@en
P2093
P2860
P356
P1476
Isolation and characterization ...... line resistant to doxorubicin.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1986.206
P407
P577
1986-09-01T00:00:00Z